Replies to post #430 on Galectin Therapeutics Inc. (GALT)

[biotech2010]

Anyone who sells a single share of GALT right now is out of their minds.

Didn't any of you read the Aegis Capital analyst change in target price report that drove the stock much higher this afternoon?

If you haven't then maybe you should, then you will understand.

And until then, you don't know anything about where this stock ould go in the next few days and months.